FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

einar gudlaugsson

Research Profile

Disorders

Chemicals & Drugs

Procedures

Phenomena

Mitotic Index

Anatomy

Lymph Nodes

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Weiwei Feng; einar gudlaugsson; Keqin Hua; Anais Malpica; Stanley J Robboy; Xianrong Zhou; Jan P A Baak
Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
Weiwei Feng; einar gudlaugsson; Emiel Janssen; Anais Malpica; Yu Yinhua; Xianrong Zhou; Jan P A Baak
Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours.
Weiwei Feng; einar gudlaugsson; Keqin Hua; Yinhua Yu; Xianrong Zhou; Jan P A Baak
Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of einar gudlaugsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Weiwei Feng; einar gudlaugsson; Keqin Hua; Anais Malpica; Stanley J Robboy; Xianrong Zhou; Jan P A Baak
Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2013;32(3):299-306.
2013: Weiwei Feng; einar gudlaugsson; Emiel Janssen; Anais Malpica; Yu Yinhua; Xianrong Zhou; Jan P A Baak
Diagnostic and prognostic morphometric features in WHO2003 invasive endometrial stromal tumours.
Histopathology 2013;62(5):688-94.
2013: Weiwei Feng; einar gudlaugsson; Keqin Hua; Yinhua Yu; Xianrong Zhou; Jan P A Baak
Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.
Histopathology 2013;62(5):675-87.
2013: einar gudlaugsson; Emiel A M Janssen; Jan Klos; Anais Malpica; Zhimin Shao; Ivar Skaland; Rune Smaaland; Weiwei Feng; Jan Pa Baak
Prognostic comparison of the proliferation markers mitotic activity index, phosphohistone H3, Ki67, steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T1-2N0M0 breast cancer.
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013;64(1):1-8.
2012: Ane Cecilie Munk; Irene Tveiteras Ovestad; Ivar Skaland; Bent Fiane; einar gudlaugsson; Bianca van Diermen Hidle; Emiel A M Janssen; Arnold-Jan Kruse; Kjell Lovslett; Jan P A Baak
Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2-3 regression.
Gynecologic oncology 2012;127(3):489-94.
2012: einar gudlaugsson; Emiel A M Janssen; Anais Malpica; Zhiming Shao; Ivar Skaland; Rune Smaaland; Feja Voorhorst; Jan P A Baak
Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer.
Histopathology 2012;61(6):1134-44.
2012: Kristin Jonsdottir; Ivar Skaland; Aida Slewa; Rune Smaaland; Hui Zhang; Benny Björkblom; Eleanor T Coffey; einar gudlaugsson; Emiel A M Janssen; Darshni Jhagroe; Jan P A Baak
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.
Breast cancer research and treatment 2012;135(2):381-90.
2012: Kjetil Søreide; einar gudlaugsson; Kjersti Mangseth; Oddvar M Sandvik; Jon Arne Søreide; Hans Kristian Haugland
Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2012;14(8):619-29.
2012: Kristin Jonsdottir; Ivar Skaland; Susanne R Janssen; Jan P A Baak; Fabiana C Da Rosa; einar gudlaugsson; Emiel A M Janssen
Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
PloS one 2012;7(11):e48692.
2012: Ane Cecilie Munk; Irene Tveiterås Ovestad; Ivar Skaland; Bianca van Diermen-Hidle; Bent Fiane; einar gudlaugsson; Emiel A M Janssen; Arnold-Jan Kruse; Kjell Løvslett; Jan Pa Baak
Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study.
Infectious agents and cancer 2012;7(1):30.
2012: Ane Cecilie Munk; Feja J Voorhorst; Irene Tveiterås Øvestad; Bent Fiane; einar gudlaugsson; Emiel A M Janssen; Arnold-Jan Kruse; Kjell I Løvslett; Anais Malpica; Jan P A Baak
Consistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3.
PloS one 2012;7(9):e45114.
2011: Kristian Storli; Tore Bru; Ida R K Bukholm; Bjørg Furnes; einar gudlaugsson; Sabine Leh; Idunn Nesvik; Solveig Norheim-Andersen; Karl Søndenaa; Geir Eide
Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III.
World journal of surgery 2011;35(12):2796-803.
2011: Oddvar M Sandvik; einar gudlaugsson; Jan Terje Kvaløy; Kjetil Søreide; Jon Arne Søreide
Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades.
Cancer epidemiology 2011;35(6):515-20.
2011: Irene T Ovestad; Undis Vennestrøm; Feja J Voorhorst; Liv Andersen; Weiwei Feng; einar gudlaugsson; Emiel A M Janssen; Anais Malpica; Ane Cecilie Munk; Jan P A Baak
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3.
Gynecologic oncology 2011;123(2):278-83.
2011: Kai-Erik Uleberg; Bianca van Diermen; Weiwei Feng; Cristina Furlan; einar gudlaugsson; Anne Hjelle; Emiel A M Janssen; Anais Malpica; Ane Cecilie Munk; Ivar Skaland; Jan P A Baak
A protein profile study to discriminate CIN lesions from normal cervical epithelium.
Cellular oncology (Dordrecht) 2011;34(5):443-50.
2011: Anita Steinbakk; Yu Yinhua; Mark Arends; Weiwei Feng; einar gudlaugsson; Emiel A M Janssen; Arnold-Jan Kruse; Anais Malpica; Aida Slewa; Jan P Baak
High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.
Cellular oncology (Dordrecht) 2011;34(5):457-65.
2011: Anita Steinbakk; Yu Yinhua; Weiwei Feng; Bent Fiane; einar gudlaugsson; Emiel A M Janssen; Arnold-Jan Kruse; Kjell Løvslett; Anais Malpica; Ivar Skaland; Aida Slewa; Jan P Baak
Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(9):1262-71.
2011: Irene Tveiterås Ovestad; einar gudlaugsson; Ivar Skaland; Anais Malpica; Ane Cecilie Munk; Emiel A M Janssen; Jan P Baak
The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3.
Journal of clinical pathology 2011;64(4):303-7.
2011: Anita Steinbakk; einar gudlaugsson; Ole Gunnar Aasprong; Ivar Skaland; Anais Malpica; Weiwei Feng; Emiel A M Janssen; Jan P Baak
Molecular biomarkers in endometrial hyperplasias predict cancer progression.
American journal of obstetrics and gynecology 2011;204(4):357.e1-12.
2011: einar gudlaugsson; Ivar Skaland; Erling Undersrud; Emiel A M Janssen; Håvard Søiland; Jan P A Baak
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(4):502-11.
2011: Tone Hoel Lende; Emiel A M Janssen; einar gudlaugsson; Feja J Voorhorst; Rune Smaaland; Paulus van Diest; Håvard Søiland; Jan P A Baak
In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):852-8.
2011: Hui Zhang; Aida Slewa; Emiel Janssen; Ivar Skaland; Yinhua Yu; einar gudlaugsson; Weiwei Feng; Kjell Kjellevold; Håvard Søiland; Jan P A Baak
The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer.
Anticancer research 2011;31(2):443-9.
2011: Kai-Erik Uleberg; Bianca van Diermen; Cato Brede; einar gudlaugsson; Anne Hjelle; Emiel A M Janssen; Anais Malpica; Ane Cecilie Munk; Ivar Skaland; Jan Pa Baak
Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.
Proteome science 2011;9():36.
2010: Emiel A M Janssen; Aida Slewa; einar gudlaugsson; Kristin Jonsdottir; Ivar Skaland; Håvard Søiland; Jan P A Baak
Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(12):1567-76.
2010: S J A Johnsen; T Valborgland; einar gudlaugsson; L Bostad; Roald Omdal
Thrombotic microangiopathy and the antiphospholipid syndrome.
Lupus 2010;19(13):1569-72.
2010: Irene Tveiterås Øvestad; einar gudlaugsson; Ivar Skaland; Anais Malpica; Arnold-Jan Kruse; Emiel A M Janssen; Jan P A Baak
Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(9):1231-40.
2010: einar gudlaugsson; Ivar Skaland; Emiel A M Janssen; Paulus van Diest; Feja J Voorhorst; Kjell H Kjellevold; Axel zur Hausen; Jan P A Baak
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Breast cancer research and treatment 2010;121(1):35-40.
2010: Anita Steinbakk; Anais Malpica; Aida Slewa; einar gudlaugsson; Emiel A M Janssen; Mark Arends; Arnold-Jan Kruse; Yu Yinhua; Weiwei Feng; Jan P Baak
High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.
Analytical cellular pathology (Amsterdam) 2010;33(5):245-55.
2010: Ivar Skaland; Marit Nordhus; einar gudlaugsson; Jan Klos; Kjell H Kjellevold; Emiel A M Janssen; Jan P A Baak
Evaluation of 5 different labeled polymer immunohistochemical detection systems.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2010;18(1):90-6.
2009: Jan P A Baak; einar gudlaugsson; Ivar Skaland; Lydia Hui Ru Guo; Jan Klos; Tone Hoel Lende; Håvard Søiland; Emiel A M Janssen; Axel Zur Hausen
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.
Breast cancer research and treatment 2009;115(2):241-54.
2009: Ivar Skaland; Emiel A M Janssen; einar gudlaugsson; Jan Klos; Kjell H Kjellevold; Håvard Søiland; Jan P A Baak
Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.
Breast cancer research and treatment 2009;114(1):39-45.
2009: Håvard Søiland; Emiel A M Janssen; Hartwig Kørner; Jan Erik Varhaug; Ivar Skaland; einar gudlaugsson; Jan P A Baak; Jon Arne Søreide
Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer.
Breast cancer research and treatment 2009;113(3):519-28.
2009: Emiel A M Janssen; Irene T Øvestad; Ivar Skaland; Håvard Søiland; einar gudlaugsson; Kjell H Kjellevold; Arne Nysted; Jon Arne Søreide; Jan P A Baak
LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(5):335-43.
2009: Ivar Skaland; Emiel A M Janssen; einar gudlaugsson; Lydia Hui Ru Guo; Jan P A Baak
The prognostic value of the proliferation marker phosphohistone H3 (PPH3) in luminal, basal-like and triple negative phenotype invasive lymph node-negative breast cancer.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(4):261-71.
2009: Håvard Søiland; Ivar Skaland; Jan Erik Varhaug; Hartwig Kørner; Emiel A M Janssen; einar gudlaugsson; Jan P A Baak; Jon Arne Søreide
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Acta oncologica (Stockholm, Sweden) 2009;48(4):514-21.
2009: Anita Steinbakk; Ivar Skaland; einar gudlaugsson; Emiel A M Janssen; Kjell H Kjellevold; Jan Klos; Kjell Løvslett; Bent Fiane; Jan P A Baak
The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.
American journal of obstetrics and gynecology 2009;200(1):78.e1-8.
2008: Håvard Søiland; Hartwig Kørner; Ivar Skaland; Emiel A M Janssen; einar gudlaugsson; Jan Erik Varhaug; Jan P A Baak; Jon Arne Søreide
Prognostic relevance of androgen receptor detection in operable breast cancer.
Journal of surgical oncology 2008;98(7):551-8.
2008: Ivar Skaland; Paulus van Diest; Emiel Janssen; einar gudlaugsson; Jan P A Baak
Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
Human pathology 2008;39(4):584-90.
2008: Arnold-Jan Kruse; Ivar Skaland; Ane Cecilie Munk; Emiel Janssen; einar gudlaugsson; Jan P A Baak
Low p53 and retinoblastoma protein expression in cervical intraepithelial neoplasia grade 3 lesions is associated with coexistent adenocarcinoma in situ.
Human pathology 2008;39(4):573-8.
2008: Kjetil Søreide; einar gudlaugsson; Ivar Skaland; Emiel Janssen; Bianca van Diermen; Hartwig Körner; Jan P A Baak
Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin.
International journal of colorectal disease 2008;23(4):389-400.
2008: Jan P A Baak; Paulus van Diest; Emiel Janssen; einar gudlaugsson; Feja J Voorhorst; ELSKEN VAN DER WALL; Jan B Vermorken
Proliferation accurately identifies the high-risk patients among small, low-grade, lymph node-negative invasive breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):649-54.
2008: Håvard Søiland; Ivar Skaland; Emiel Janssen; einar gudlaugsson; Hartwig Körner; Jan Erik Varhaug; Jon Arne Søreide; Jan P A Baak
Comparison of apolipoprotein D determination methods in breast cancer.
Anticancer research 2008;28(2B):1151-60.
2007: Ane Cecilie Munk; Arnold-Jan Kruse; Bianca van Diermen; Emiel Janssen; Ivar Skaland; einar gudlaugsson; Stein Tore Nilsen; Jan P A Baak
Cervical intraepithelial neoplasia grade 3 lesions can regress.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007;115(12):1409-14.
2007: Ivar Skaland; Emiel Janssen; einar gudlaugsson; Jan Klos; Kjell H Kjellevold; Håvard Søiland; Jan P A Baak
Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(12):1307-15.
2007: Jan P A Baak; Paulus van Diest; Feja J Voorhorst; ELSKEN VAN DER WALL; Louk V A M Beex; Jan B Vermorken; Emiel Janssen; einar gudlaugsson
The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
European journal of cancer (Oxford, England : 1990) 2007;43(3):527-35.
2007: Kjetil Soreide; Tirza C E Buter; Emiel Janssen; einar gudlaugsson; Ivar Skaland; Hartwig Körner; Jan P A Baak
Cell-cycle and apoptosis regulators (p16INK4A, p21CIP1, beta-catenin, survivin, and hTERT) and morphometry-defined MPECs predict metachronous cancer development in colorectal adenoma patients.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(4):301-13.
2007: Emiel Janssen; Håvard Søiland; Ivar Skaland; einar gudlaugsson; Kjell H Kjellevold; Arne Nysted; Jon Arne Søreide; Jan P A Baak
Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(1):25-35.
2006: Jon Arne Søreide; Kjetil Søreide; Hartwig Körner; Håvard Søiland; Ole Jacob Greve; einar gudlaugsson
Benign peritoneal cystic mesothelioma.
World journal of surgery 2006;30(4):560-6.
2006: Emiel Janssen; Paulus van Diest; Håvard Søiland; einar gudlaugsson; Arne Nysted; Feja J Voorhorst; Jan B Vermorken; Jon Arne Søreide; Jan P A Baak
Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2006;28(5-6):295-303.
2005: Kjetil Søreide; einar gudlaugsson; Kjell H Kjellevold
[Appendiceal mucinous cystadenoma].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(3):289-91.
2004: Karl Søndenaa; Jon Sen; Frank Heinle; Lars Fjetland; einar gudlaugsson; Unni Syversen
Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.
World journal of surgery 2004;28(9):890-5.
2004: Arnold-Jan Kruse; einar gudlaugsson; Tove Helliesen; Emiel Janssen; Bianca van Diermen; Silje Sandvik; Jan P A Baak
Evaluation of prospective, routine application of Ki-67 immunoquantitation in early CIN for assessment of short-term progression risk.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2004;26(3):134-40.